ENTRY       D04268                      Drug
NAME        Elastase ES;
            Elaszym (TN)
CLASS       Hypolipidemic agent
             DG01946  Hypolipidemic agent
REMARK      Therapeutic category: 2189
            Product: D04268<JP>
EFFICACY    Antihyperlipidemic, Cholesterol catabolism enhancer, Lipoprotein lipase (LPL) activator, Lecithin-cholesterol acyltransferase (LCAT) activator
TARGET      LPL [HSA:4023] [KO:K01059]
            LCAT [HSA:3931] [KO:K00650]
  PATHWAY   hsa00561(4023)  Glycerolipid metabolism
            hsa03320(4023)  PPAR signaling pathway
            hsa04979(3931+4023)  Cholesterol metabolism
INTERACTION  
STR_MAP     map07052  Antidyslipidemic agents
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               218  Hyperlipidemia agents
                2189  Others
                 D04268  Elastase ES
            Drug groups [BR:br08330]
             Hypolipidemic agent
              DG01946  Hypolipidemic agent
               D04268  Elastase ES
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01946  Hypolipidemic agent
               D04268  Elastase ES
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Acyltransferases
                LCAT
                 D04268  Elastase ES &lt;JP&gt;
              Hydrolases (EC3)
               Carboxylic-ester hydrolases
                LPL
                 D04268  Elastase ES &lt;JP&gt;
DBLINKS     CAS: 9004-06-2
            PubChem: 17398042
///
